OpenAlex
Works that cite this article, indexed by OpenAlex.
Efficacy, acceptability, and safety of muscle relaxants for adults with non-specific low back pain: systematic review and meta-analysis
BMJ 374 (2021)
Aidan Gregory Cashin; Thiago Folly; Matthew K. Bagg; Michael A. Wewege; Matthew D Jones; Michael C Ferraro; Hayley B. Leake; Rodrigo R N Rizzo; Siobhan M. Schabrun; Sylvia Maria Gustin; Richard Osborne Day; Christopher Michael Williams; James Henry McAuley
Treatment for chronic low back pain: the focus should change to multimodal management that reflects the underlying pain mechanisms
Current Medical Research and Opinion 33(7) (2017)
Gerhard H. H. Müller-Schwefe; Bart J. Morlion; Karsten Ahlbeck; Eli Alon; Stefano Coaccioli; Flaminia Coluzzi; Frank J.P.M. Huygen; Wolfgang Jaksch; Eija Anneli Kalso; Magdalena Kocot-Kępska; Hans Georg Kress; Ana Cristina Mangas; César Margarit Ferrí; Philippe Mavrocordatos; Andrew Nicolaou; Concepción Pérez Hernández; Joseph V. Pergolizzi; Michael Schäfer; Patrick Sichère
Effect of therapeutic exercise on knee osteoarthritis after intra-articular injection of botulinum toxin type A, hyaluronate or saline: A randomized controlled trial
Journal of Rehabilitation Medicine 50(6) (2018)
X Bao; J W Y Tan; Mike Flyzik; Xinlong Ma; Hui-Yu Liu; Hui-Yu Liu
Treatment methods for post-traumatic elbow stiffness caused by heterotopic ossification
Journal of Shoulder and Elbow Surgery 29(7) (2020)
Christina E. Freibott; Henrik C. Bäcker; Seth C. Shoap; Liana J. Tedesco; Samuel E. Galle; Melvin Paul Rosenwasser
Invasive Treatments for Low Back Disorders
Journal of Occupational and Environmental Medicine 63(4) (2021)
Kurt T. Hegmann; Russell L. Travis; Gunnar B. J. Andersson; Roger M. Belcourt; Eugene J. Carragee; Marjorie Eskay-Auerbach; Jill S. Galper; Michael Goertz; Scott Haldeman; Paul D. Hooper; James E. Lessenger; Tom G. Mayer; Kathryn L. Mueller; Donald R. Murphy; William G. Tellin; Matthew S. Thiese; Michael Weiss; Jeffrey S. Harris
Are paraspinous intramuscular injections of botulinum toxin a (BoNT-A) efficient in the treatment of chronic low-back pain? A randomised, double-blinded crossover trial
BMC Musculoskeletal Disorders 18(1) (2017)
Mélanie Cogné; H Petit; Alexandre Creuzé; Dominique Liguoro; Mathieu de Sèze
Abobotulinum Toxin A in the Treatment of Chronic Low Back Pain
Toxins 8(12) (2016)
Duarte Machado; Aditya Kumar; Bahman Jabbari
Injection Botulinum Toxin A in Treatment of Resistant Chronic Low Back Pain: A Prospective Open-Label Study
Cureus 13(9) (2021)
Jagannatha Sahoo; Debasish Jena; Amrutha Viswanath; Apurba Barman
The Efficacy and Safety of Botulinum Neurotoxin Type A in Treating Chronic Low Back Pain: A Systematic Review, Meta‐Analysis, Trial Sequential Analysis, and Meta‐Regression
European Journal of Pain 29(4) (2025)
Waseem Wagrees; Hesham Kelani; Hazem Mohamed Salamah; Abdelrahman Mahmoud; Yehya Khlidj; Mohamed R. Abdelraouf; Bahaa Sharaf; Moustafa Elnewishy; Nadia Albaramony; Ahmed Naeem; Ahmed Abd Elazim; Mohammad H El-Ghanem; Diana Greene‐Chandos; Mohammad Jadidi; David P. Lerner; Arthur D. Kay; Lisa R. Merlin; Charles W. Brock
Botulinum toxin type A for treating chronic low back pain: A double blinded randomized control study
World Journal of Methodology 14(3) (2024)
Mantu Jain; Shahnawaz Khan; Paulson Varghese; Sujit Kumar Tripathy; Manaswini Mangaraj
Botulinum toxin in management of back pain
Quality in Sport 15 (2024)
Blanka Łuczak; Bianka Nowińska; Katarzyna Słychan; Izabela Hądzlik; Jan Piotrowski; Julia Biały-Karbowniczek; Klaudia Bulska; Patrycja Brzozowska; Andrzej Piela; Konrad Sławek